Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Apr;227(4):559–565. doi: 10.1097/00000658-199804000-00018

Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size.

E J Patterson 1, C H Scudamore 1, D A Owen 1, A G Nagy 1, A K Buczkowski 1
PMCID: PMC1191313  PMID: 9563546

Abstract

OBJECTIVE: To determine, in vivo, the effect of radiofrequency ablation (RFA) treatment time and tissue blood flow on the size and shape of the resulting necrotic lesion in porcine liver. SUMMARY BACKGROUND DATA: Radiofrequency ablation is an electrosurgical technique that uses a high frequency alternating current to heat tissues to the point of desiccation (thermal coagulation). Radiofrequency ablation is well established as the treatment of choice for many symptomatic cardiac arrhythmias because of its ability to create localized necrotic lesions in the cardiac conducting system. Until recently, a major limitation of RFA was the small lesion size created by this technique. Development of bipolar and multiple-electrode RFA probes has enabled the creation of larger lesions and therefore has expanded the potential clinical applications of RFA, which includes the treatment of liver tumors. A basic understanding of factors that influence RFA lesion size in vivo is critical to the success of this treatment modality. The optimal RFA technique, which maximizes liver lesion size, has yet to be determined. Theoretically, lesion size varies directly with time of application of the RF current, and inversely with blood flow, but these relationships have not been previously studied in the liver. METHODS: Six animals underwent hepatic RFA (460 kHz), for 5, 7.5, 10, 12.5, 15, and 20 minutes. Identical, predetermined anatomic areas of the liver were ablated in each animal. Two additional animals underwent 12 RFA treatments -- 6 with vascular inflow occlusion (Pringle maneuver) and 6 with uninterrupted hepatic blood flow. Animals were euthanized and the livers were removed for gross pathologic examination. All lesions were measured in three dimensions and photographed. Tissues were examined by routine histology and by histochemistry to determine viability. RESULTS: Increasing duration of RFA application from 5 through 20 minutes did not create lesions of larger diameter, but this time increase did predict deeper lesion production (beta = 0.34, p = 0.04). A range of lesion shapes were created from four separate ovals (corresponding to each electrode), to larger ovals intersecting to form a cross, to spheroid lesions. The number of blood vessels in close proximity to the probe tip (within a 1-cm radius from the center of the lesion) strongly predicted minimum lesion diameter (beta = -0.61, p = 0.0001) and lesion volume (beta = -0.56, p = 0.0004). This negative effect of blood flow on lesion size was confirmed experimentally. Radiofrequency ablation lesions created during a Pringle maneuver were significantly larger in all three dimensions than lesions created without a Pringle maneuver: minimum diameter was 3.0 cm (with Pringle) versus 1.2 cm (p = 0.002), maximum diameter was 4.5 cm (with Pringle) versus 3.1 cm (p = 0.002), depth was 4.8 cm (with Pringle) versus 3.1 cm (p < 0.001), and lesion volume was 35.0 cm3 (with Pringle) versus 6.5 cm3 (p < 0.001). CONCLUSIONS: Blood flow is a strong predictor of all RFA lesion dimensions in porcine liver in vivo, whereas a change of treatment time from 5 to 20 minutes is predictive only of lesion depth, but not diameter or volume.

Full text

PDF
559

Images in this article

561Figure 1.
on p.561
564Figure 8.
on p.564

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buscarini L., Rossi S., Fornari F., Di Stasi M., Buscarini E. Laparoscopic ablation of liver adenoma by radiofrequency electrocauthery. Gastrointest Endosc. 1995 Jan;41(1):68–70. doi: 10.1016/s0016-5107(95)70279-2. [DOI] [PubMed] [Google Scholar]
  2. D'Agostino H. B., Solinas A. Percutaneous ablation therapy for hepatocellular carcinomas. AJR Am J Roentgenol. 1995 May;164(5):1165–1167. doi: 10.2214/ajr.164.5.7717225. [DOI] [PubMed] [Google Scholar]
  3. Haines D. E. The biophysics of radiofrequency catheter ablation in the heart: the importance of temperature monitoring. Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 2):586–591. doi: 10.1111/j.1540-8159.1993.tb01630.x. [DOI] [PubMed] [Google Scholar]
  4. Hamazoe R., Hirooka Y., Ohtani S., Katoh T., Kaibara N. Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinoma. Cancer. 1995 Feb 1;75(3):794–800. doi: 10.1002/1097-0142(19950201)75:3<794::aid-cncr2820750308>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  5. Hamazoe R., Maeta M., Murakami A., Yamashiro H., Kaibara N. Heating efficiency of radiofrequency capacitive hyperthermia for treatment of deep-seated tumors in the peritoneal cavity. J Surg Oncol. 1991 Nov;48(3):176–179. doi: 10.1002/jso.2930480307. [DOI] [PubMed] [Google Scholar]
  6. LeVeen H. H., Wapnick S., Piccone V., Falk G., Ahmed Nafis Tumor eradication by radiofrequency therapy. Responses in 21 patients. JAMA. 1976 May 17;235(20):2198–2200. [PubMed] [Google Scholar]
  7. McGahan J. P., Browning P. D., Brock J. M., Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 1990 Mar;25(3):267–270. doi: 10.1097/00004424-199003000-00011. [DOI] [PubMed] [Google Scholar]
  8. Nath S., Haines D. E. Biophysics and pathology of catheter energy delivery systems. Prog Cardiovasc Dis. 1995 Jan-Feb;37(4):185–204. doi: 10.1016/s0033-0620(05)80006-4. [DOI] [PubMed] [Google Scholar]
  9. Onik G. M., Atkinson D., Zemel R., Weaver M. L. Cryosurgery of liver cancer. Semin Surg Oncol. 1993 Jul-Aug;9(4):309–317. doi: 10.1002/ssu.2980090406. [DOI] [PubMed] [Google Scholar]
  10. Organ L. W. Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol. 1976;39(2):69–76. doi: 10.1159/000102478. [DOI] [PubMed] [Google Scholar]
  11. Rossi S., Di Stasi M., Buscarini E., Cavanna L., Quaretti P., Squassante E., Garbagnati F., Buscarini L. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am. 1995 May-Jun;1(1):73–81. [PubMed] [Google Scholar]
  12. Rossi S., Di Stasi M., Buscarini E., Quaretti P., Garbagnati F., Squassante L., Paties C. T., Silverman D. E., Buscarini L. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol. 1996 Sep;167(3):759–768. doi: 10.2214/ajr.167.3.8751696. [DOI] [PubMed] [Google Scholar]
  13. Scheele J., Stang R., Altendorf-Hofmann A., Paul M. Resection of colorectal liver metastases. World J Surg. 1995 Jan-Feb;19(1):59–71. doi: 10.1007/BF00316981. [DOI] [PubMed] [Google Scholar]
  14. Schulman C. C., Vanden Bossche M. Hyperthermia and thermotherapy of benign prostatic hyperplasia: a critical review. Eur Urol. 1993;23 (Suppl 1):53–59. doi: 10.1159/000474681. [DOI] [PubMed] [Google Scholar]
  15. Strohbehn J. W. Temperature distributions from interstitial rf electrode hyperthermia systems: theoretical predictions. Int J Radiat Oncol Biol Phys. 1983 Nov;9(11):1655–1667. doi: 10.1016/0360-3016(83)90419-4. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES